Copyright Reports & Markets. All rights reserved.

Global Artificial Pancreas Devices System Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Artificial Pancreas Devices System Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Artificial Pancreas Devices System Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Threshold Suspend Device System
    • 1.4.3 Non-Threshold Suspend Device System (NTSDS)
    • 1.4.4 Control to Range System (CTRS)
    • 1.4.5 Control to Target System (CTTS)
  • 1.5 Market by Application
    • 1.5.1 Global Artificial Pancreas Devices System Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Artificial Pancreas Devices System Market Perspective (2015-2026)
  • 2.2 Global Artificial Pancreas Devices System Growth Trends by Regions
    • 2.2.1 Artificial Pancreas Devices System Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Artificial Pancreas Devices System Historic Market Share by Regions (2015-2020)
    • 2.2.3 Artificial Pancreas Devices System Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Artificial Pancreas Devices System Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Artificial Pancreas Devices System Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Artificial Pancreas Devices System Players by Market Size
    • 3.1.1 Global Top Artificial Pancreas Devices System Players by Revenue (2015-2020)
    • 3.1.2 Global Artificial Pancreas Devices System Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Artificial Pancreas Devices System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Artificial Pancreas Devices System Market Concentration Ratio
    • 3.2.1 Global Artificial Pancreas Devices System Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Artificial Pancreas Devices System Revenue in 2019
  • 3.3 Artificial Pancreas Devices System Key Players Head office and Area Served
  • 3.4 Key Players Artificial Pancreas Devices System Product Solution and Service
  • 3.5 Date of Enter into Artificial Pancreas Devices System Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Artificial Pancreas Devices System Historic Market Size by Type (2015-2020)
  • 4.2 Global Artificial Pancreas Devices System Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Artificial Pancreas Devices System Market Size by Application (2015-2020)
  • 5.2 Global Artificial Pancreas Devices System Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Artificial Pancreas Devices System Market Size (2015-2020)
  • 6.2 Artificial Pancreas Devices System Key Players in North America (2019-2020)
  • 6.3 North America Artificial Pancreas Devices System Market Size by Type (2015-2020)
  • 6.4 North America Artificial Pancreas Devices System Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Artificial Pancreas Devices System Market Size (2015-2020)
  • 7.2 Artificial Pancreas Devices System Key Players in Europe (2019-2020)
  • 7.3 Europe Artificial Pancreas Devices System Market Size by Type (2015-2020)
  • 7.4 Europe Artificial Pancreas Devices System Market Size by Application (2015-2020)

8 China

  • 8.1 China Artificial Pancreas Devices System Market Size (2015-2020)
  • 8.2 Artificial Pancreas Devices System Key Players in China (2019-2020)
  • 8.3 China Artificial Pancreas Devices System Market Size by Type (2015-2020)
  • 8.4 China Artificial Pancreas Devices System Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Artificial Pancreas Devices System Market Size (2015-2020)
  • 9.2 Artificial Pancreas Devices System Key Players in Japan (2019-2020)
  • 9.3 Japan Artificial Pancreas Devices System Market Size by Type (2015-2020)
  • 9.4 Japan Artificial Pancreas Devices System Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Artificial Pancreas Devices System Market Size (2015-2020)
  • 10.2 Artificial Pancreas Devices System Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Artificial Pancreas Devices System Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Artificial Pancreas Devices System Market Size by Application (2015-2020)

11 India

  • 11.1 India Artificial Pancreas Devices System Market Size (2015-2020)
  • 11.2 Artificial Pancreas Devices System Key Players in India (2019-2020)
  • 11.3 India Artificial Pancreas Devices System Market Size by Type (2015-2020)
  • 11.4 India Artificial Pancreas Devices System Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Artificial Pancreas Devices System Market Size (2015-2020)
  • 12.2 Artificial Pancreas Devices System Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Artificial Pancreas Devices System Market Size by Type (2015-2020)
  • 12.4 Central & South America Artificial Pancreas Devices System Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Medtronic
    • 13.1.1 Medtronic Company Details
    • 13.1.2 Medtronic Business Overview
    • 13.1.3 Medtronic Artificial Pancreas Devices System Introduction
    • 13.1.4 Medtronic Revenue in Artificial Pancreas Devices System Business (2015-2020))
    • 13.1.5 Medtronic Recent Development
  • 13.2 Johnson & Johnson
    • 13.2.1 Johnson & Johnson Company Details
    • 13.2.2 Johnson & Johnson Business Overview
    • 13.2.3 Johnson & Johnson Artificial Pancreas Devices System Introduction
    • 13.2.4 Johnson & Johnson Revenue in Artificial Pancreas Devices System Business (2015-2020)
    • 13.2.5 Johnson & Johnson Recent Development
  • 13.3 Insulet
    • 13.3.1 Insulet Company Details
    • 13.3.2 Insulet Business Overview
    • 13.3.3 Insulet Artificial Pancreas Devices System Introduction
    • 13.3.4 Insulet Revenue in Artificial Pancreas Devices System Business (2015-2020)
    • 13.3.5 Insulet Recent Development
  • 13.4 Tandem Diabetes Care
    • 13.4.1 Tandem Diabetes Care Company Details
    • 13.4.2 Tandem Diabetes Care Business Overview
    • 13.4.3 Tandem Diabetes Care Artificial Pancreas Devices System Introduction
    • 13.4.4 Tandem Diabetes Care Revenue in Artificial Pancreas Devices System Business (2015-2020)
    • 13.4.5 Tandem Diabetes Care Recent Development
  • 13.5 Roche
    • 13.5.1 Roche Company Details
    • 13.5.2 Roche Business Overview
    • 13.5.3 Roche Artificial Pancreas Devices System Introduction
    • 13.5.4 Roche Revenue in Artificial Pancreas Devices System Business (2015-2020)
    • 13.5.5 Roche Recent Development
  • 13.6 Beta Bionics
    • 13.6.1 Beta Bionics Company Details
    • 13.6.2 Beta Bionics Business Overview
    • 13.6.3 Beta Bionics Artificial Pancreas Devices System Introduction
    • 13.6.4 Beta Bionics Revenue in Artificial Pancreas Devices System Business (2015-2020)
    • 13.6.5 Beta Bionics Recent Development
  • 13.7 Bigfoot Biomedical
    • 13.7.1 Bigfoot Biomedical Company Details
    • 13.7.2 Bigfoot Biomedical Business Overview
    • 13.7.3 Bigfoot Biomedical Artificial Pancreas Devices System Introduction
    • 13.7.4 Bigfoot Biomedical Revenue in Artificial Pancreas Devices System Business (2015-2020)
    • 13.7.5 Bigfoot Biomedical Recent Development
  • 13.8 Cellnovo
    • 13.8.1 Cellnovo Company Details
    • 13.8.2 Cellnovo Business Overview
    • 13.8.3 Cellnovo Artificial Pancreas Devices System Introduction
    • 13.8.4 Cellnovo Revenue in Artificial Pancreas Devices System Business (2015-2020)
    • 13.8.5 Cellnovo Recent Development
  • 13.9 Dexcom
    • 13.9.1 Dexcom Company Details
    • 13.9.2 Dexcom Business Overview
    • 13.9.3 Dexcom Artificial Pancreas Devices System Introduction
    • 13.9.4 Dexcom Revenue in Artificial Pancreas Devices System Business (2015-2020)
    • 13.9.5 Dexcom Recent Development
  • 13.10 Dose Safety
    • 13.10.1 Dose Safety Company Details
    • 13.10.2 Dose Safety Business Overview
    • 13.10.3 Dose Safety Artificial Pancreas Devices System Introduction
    • 13.10.4 Dose Safety Revenue in Artificial Pancreas Devices System Business (2015-2020)
    • 13.10.5 Dose Safety Recent Development
  • 13.11 DreaMed Diabetes
    • 10.11.1 DreaMed Diabetes Company Details
    • 10.11.2 DreaMed Diabetes Business Overview
    • 10.11.3 DreaMed Diabetes Artificial Pancreas Devices System Introduction
    • 10.11.4 DreaMed Diabetes Revenue in Artificial Pancreas Devices System Business (2015-2020)
    • 10.11.5 DreaMed Diabetes Recent Development
  • 13.12 Inreda Diabetic
    • 10.12.1 Inreda Diabetic Company Details
    • 10.12.2 Inreda Diabetic Business Overview
    • 10.12.3 Inreda Diabetic Artificial Pancreas Devices System Introduction
    • 10.12.4 Inreda Diabetic Revenue in Artificial Pancreas Devices System Business (2015-2020)
    • 10.12.5 Inreda Diabetic Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Artificial Pancreas Devices System market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Pancreas Devices System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Medtronic
    Johnson & Johnson
    Insulet
    Tandem Diabetes Care
    Roche
    Beta Bionics
    Bigfoot Biomedical
    Cellnovo
    Dexcom
    Dose Safety
    DreaMed Diabetes
    Inreda Diabetic

    Market segment by Type, the product can be split into
    Threshold Suspend Device System
    Non-Threshold Suspend Device System (NTSDS)
    Control to Range System (CTRS)
    Control to Target System (CTTS)
    Market segment by Application, split into
    Hospitals
    Clinics
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now